LETICIA CRUZ: Open Payments
NPI 1023103900 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$755 in 32 payments from 11 companies in 2025. Trend: 2023 $904 · 2024 $857 · 2025 $755
Food & beverage: $755
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $207 |
| Novo Nordisk Inc | 8 | $139 |
| PFIZER INC. | 5 | $122 |
| Lilly USA, LLC | 4 | $69 |
| Exact Sciences Corporation | 3 | $51 |
| Amgen Inc. | 3 | $46 |
| ABBVIE INC. | 2 | $38 |
| SANOFI PASTEUR INC. | 1 | $24 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| IBSA Pharma Inc. | 1 | $20 |
Products named: AIRSUPRA, NURTEC ODT, Ozempic, MOUNJARO, Cologuard Collection Kit, Rybelsus, SYNTHROID, OTEZLA.
Industry payments across TX — which companies pay providers there.
